Health Condition 1: null- esophageal cancer
Conditions
Interventions
None listed
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: • Histologically proven esophageal carcinoma (squamous cell carcinoma or Adenocarcinoma) • PET-CT performed at Max hospital
Exclusion criteria
Exclusion criteria: • Patient clinical data not available
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Determination of indications (staging, restaging/ recurrence, chemotherapy treatment response, and radiation treatment response evaluation) for 18[F] FDG PET-CT in esophageal cancer. â?¢ Determination of the prevalence of esophageal cancer in different age group, gender, tumor location in esophagus (upper, middle, lower), histological type (squamous cell carcinoma and adenocarcinoma). Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Determination of Responder and non-Responder to the concurrent chemo- radiotherapy for esophageal cancer with the help of 18[F] FDG PET/CT and compare percentage decrease in maximum standardized uptake values (SUVmax) in pretreatment and post treatment scan. â?¢ Determination of most common metastatic site in metastatic esophageal carcinoma. Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Pankaj Dougall
Max Healthcare
Outcome results
None listed